medline.ch Gastroenterologie Oesophagus Neoplasie

	Construction and validation of a transmembrane 4 superfamily-related genes prognostic model for esophageal squamous cell carcinoma. Front Oncol Hao X, Ding H, Zhu H, Gong X, Chang Y, Liu C, Hou S. PMID: 41347075 [PubMed]
	Research trends in neoadjuvant therapy for esophageal cancer: a bibliometric and meta-analysis. Front Immunol Wang H, Zhang J, Yang J, Chang H. PMID: 41346615 [PubMed - indexed for MEDLINE]
	Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials. Front Immunol Lin Y, Liao Y, Shen J. PMID: 41346601 [PubMed - indexed for MEDLINE]
	PERi-operative selective decontamination of the digestive tract to prevent severe infectious complications after Esophageal Resection: study protocol of the PERSuaDER-trial, a multicenter randomized controlled trial in patients with primary resectable esophageal carcinoma. Trials Grootenhuis JGA, Seurs W, Garms LM, de Vries M, Ubels S, van Werkhoven HC, Rosman C, Schouten JA, Klarenbeek BR, Van Veer H. PMID: 41345690 [PubMed - as supplied by publisher]
	Ivor Lewis minimally invasive oesophagectomy versus McKeown approach: short-term benefits and mid-term equivalence in a randomized trial for oesophageal squamous cell carcinoma. Surg Endosc Xiu R, An R, Shan L, Zhang W, Cong B, Zhao X, Zhao Y. PMID: 41345532 [PubMed - as supplied by publisher]
	Risk factors of postoperative complications and prognostic factors in patients undergoing esophagectomy reconstructed with colonic interposition. Dis Esophagus Takahashi N, Okamura A, Terayama M, Kato T, Ishida H, Kanamori J, Imamura Y, Taketomi A, Watanabe M. PMID: 41343727 [PubMed - indexed for MEDLINE]
	Recent advances in risk stratification of patients with Barrett's esophagus. Dis Esophagus Perananthan V, Iyer PG. PMID: 41343724 [PubMed - indexed for MEDLINE]
	[Identification of incomplete response following neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma : Results of the preSINO study]. Chirurgie (Heidelb) Schiffmann LM, Bruns CJ. PMID: 41342916 [PubMed - as supplied by publisher]
	The mediating role of inflammation in cancer risk among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study. Int J Surg Bu J, Mi N, Liang Z, Xie P, Long C, Yang M, Yuan J, Xia B, Liu A, Xiang S, He Q. PMID: 41342547 [PubMed - as supplied by publisher]
	Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers. Front Immunol Ma J, Wu D, Liu Y, Zhang G. PMID: 41341591 [PubMed - indexed for MEDLINE]
	Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons. Adv Ther Ajani JA, Wang K, Nikolaidis GF, Coaquira Castro J, Augusto Novis de Figueiredo M, Sun JM, Soulanis K, Tasoulas A, Zhan L. PMID: 41335329 [PubMed - as supplied by publisher]
	Preoperative Short-Term Nutrition and Exercise Trial Program for Patients with Esophageal Cancer: A Randomized Clinical Trial: Thoracic Oncology. Ann Surg Oncol Kawata S, Hiramatsu Y, Honke J, Takashima S, Shirai Y, Shibata Y, Sakai Y, Haneda R, Soneda W, Murakami T, Booka E, Matsumoto T, Morita Y, Kikuchi H, Yamauchi K, Takeuchi H. PMID: 41335173 [PubMed - as supplied by publisher]
	Nutritional support and immunonutrition in esophageal cancer - From perioperative care to long-term survivorship: A review. Biomol Biomed Hussein M, Mohamed T, Mubarak FA, Morad F, Naser M, Humaira A, Amina H, Khan M. PMID: 41334710 [PubMed - as supplied by publisher]
	Validation of a blood test for multi-cancer risk stratification in a lung cancer screening cohort. medRxiv Fahrmann JF, Irajizad E, Rudsari H, Vykoukal J, Toumazis I, Khorami-Sarvestani S, Ansari S, Yang J, Kettner N, Dennison JB, Ostrin E, Hanash S. PMID: 41332848 [PubMed]
	Study protocol of a randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for advanced or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU). BMC Cancer Sakanaka K, Sasaki K, Tsushima T, Machida R, Hamai Y, Watanabe A, Kawabata K, Matsuda S, Kato K, Fukuda H, Takeuchi H, Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. PMID: 41331921 [PubMed - as supplied by publisher]
	Sarcopenia predicts poor long-term survival but not postoperative complications in gastric cancer surgery: an 18-year retrospective cohort study. World J Surg Oncol Back J, Järvinen T, Sallinen V, Puolakkainen P, Kokkola A. PMID: 41331639 [PubMed - as supplied by publisher]
	Sex and d age differences in longitudinal health-related quality of life: A population-based cohort study of oesophageal cancer survivors in Sweden. Eur J Surg Oncol Färnqvist K, Johar A, Schandl A, Lagergren P. PMID: 41330196 [PubMed - as supplied by publisher]
	Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis. Eur J Cancer Leone AG, Petrelli F, Klempner SJ, Smyth EC, Sundar R, Lordick F, Lorenzen S, Masetti M, Obermannova R, Alsina M, Janjigian YY, Pietrantonio F. PMID: 41330053 [PubMed - as supplied by publisher]
	FHIR Standard-Based Oncology Data Model for Cancer Screening: Design and Implementation Study. JMIR Cancer Mantri M, Satokar S, Tambe P, Bhutad C. PMID: 41329957 [PubMed - indexed for MEDLINE]
	Comparative effectiveness of total laryngectomy versus organ preservation in T3 laryngeal cancer: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol Merdad M, Mogharbel A, Alghamdi AS, Almansouri OS, Alahmari AF, Alqutub A. PMID: 41329200 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 37794

Seite 1 von 1890

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung